MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
American Heart Journal
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,105 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,105 works in the cohort · of 4,299,418page 4 of 23

Labels cover 0 of 1,105 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,105 of 1,105 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST
Cynthia M. Westerhout, Éric Bonnefoy, Robert C. Welsh, Philippe Gabríel Steg, Florent Boutitie, Paul W. Armstrong
2011· article· en· American Heart Journal· Medicine
distilled prediction:candidate · noneconsensus · none
104
citations
affno abstractunlabeled
Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: A comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter serial coronary computed tomographic angiography study
Sang‐Eun Lee, Hyuk‐Jae Chang, Asim Rizvi, Martin Hadamitzky, Yong‐Jin Kim, Edoardo Conte +15 more
2016· article· en· American Heart Journal· Medicine
distilled prediction:candidate · noneconsensus · none
102
citations
affno abstractunlabeled
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration
Luis Miguel Blanco‐Colio, José Luis Martín‐Ventura, Eduardo de Teresa, Csaba Farsang, Allan Gaw, Gianfranco Gensini +4 more
2007· article· en· American Heart Journal· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
100
citations
affno abstractunlabeled
Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)
Michael Böhm, Magnus Baumhäkel, Jeffrey L. Probstfield, Roland E. Schmieder, Salim Yusuf, Feng Zhao
2007· article· en· American Heart Journal· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
96
citations
affno abstractunlabeled
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients
Tullio Palmerini, Patrick W. Serruys, A. Pieter Kappetein, Philippe Généreux, Diego Della Riva, Maria Letizia Bacchi Reggiani +15 more
2017· review· en· American Heart Journal· Medicine
distilled prediction:candidate · metaepi_narrow+metaepi_broadconsensus · none
94
citations
affno abstractunlabeled
The Family Atherosclerosis Monitoring In earLY life (FAMILY) study
Katherine M. Morrison, Stephanie A. Atkinson, Salim Yusuf, Jacqueline M. Bourgeois, Sarah D. McDonald, Matthew McQueen +4 more
2009· article· en· American Heart Journal· Medicine
distilled prediction:candidate · noneconsensus · none
89
citations
affno abstractunlabeled
The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale
Robert P. Giugliano, L. Kristin Newby, Robert A. Harrington, C. Michael Gibson, Frans Van de Werf, Paul W. Armstrong +5 more
2005· article· en· American Heart Journal· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
88
citations
afffundno abstractunlabeled
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
Thomas J. Povsic, Candice Junge, Adel Nada, Richard A. Schatz, Robert A. Harrington, Charles J. Davidson +10 more
2013· article· en· American Heart Journal· Medicine
distilled prediction:candidate · noneconsensus · none
87
citations

How this was built: Screen · Findings · About